CoMMit-Myeloma Trial Innovated

11 posts

CoMMit-Myeloma Trial Innovated

CoMMit-Myeloma Trial Innovated

@CoMMitTrials

Aggregating investigators, patients and private entities to develop better therapies through efficient and patient-centered clinical trials

Katılım Kasım 2025
110 Takip Edilen100 Takipçiler
CoMMit-Myeloma Trial Innovated retweetledi
Rahul Banerjee, MD, FACP
Rahul Banerjee, MD, FACP@RahulBanerjeeMD·
#ASH25 not many investigator meetings look like this, but the @CoMMitTrials meeting thanks to @End_myeloma! 🍷 not shown, nor the 🛩️ Luciano has earned. Look for many innovative trial results coming soon, including MASTER-2 with MRD-guided decision-making!
Rahul Banerjee, MD, FACP tweet media
English
1
7
37
1.5K
CoMMit-Myeloma Trial Innovated
CoMMit-Myeloma Trial Innovated@CoMMitTrials·
Productive evening conspiring against myeloma. This fantastic group accrued >150 patients in MM treatment trials in 2025. Several key colleagues couldn't make to MCO, will join us next year.
CoMMit-Myeloma Trial Innovated tweet media
English
0
5
20
1.5K
CoMMit-Myeloma Trial Innovated
CoMMit-Myeloma Trial Innovated@CoMMitTrials·
@SusanBal9 et al published this exactly. The effect of ASCT on MRD is well known and can be used as benchmark for novel consolidation therapies pmc.ncbi.nlm.nih.gov/articles/PMC12…
Raj Chakraborty@rajshekharucms

While single-arm, the 100% MRD-negativity at 10^-6 with short course of Linvosiltemab post-induction is striking! Awaiting the FASTER RCT [Elra vs ASCT] from @CoMMitTrials but hard to imagine Mel-200 will achieve such high MRD-conversion rate based on prior data! #ASH25

English
0
1
2
435

Keşfet

@MyelomaTeacher @grpetersen1 @End_myeloma @RahulBanerjeeMD @SusanBal9 @elonmusk @BarackObama @taylorswift13